Skip Navigation
Menu
Brief Reports |1 October 1990

Transfusion of Blood Components from a Donor with Human T-Lymphotropic Virus Type II (HTLV-II) Infection

Elizabeth Donegan, MD; Michael P. Busch, MD, PhD; Janice A. Galleshaw, MD; George M. Shaw, MD, PhD; James W. Mosley, MD; Transfusion Safety Study Group*

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
The following are members of the Protocol and Data Monitoring Committee: H. J. Alter, D. J. A'Allessio, G. J. Grady, P. V. Holland, N. R. Rose, L. B. Seeff, J. Wittes.
Grant Support: By contract N01-HB-4-7002, N01-HB-4-7003, and N01-HB-9-7074 from the National Heart, Lung, and Blood Institute.
Requests for Reprints: James W. Mosley, MD, University of Southern California, 1840 North Soto Street (EDM 108), Los Angeles, CA 90032.
Current Author Addresses: Dr. Donegan: University of California, San Francisco, Department of Laboratory Medicine, P.O. Box 0100, San Francisco, CA 94143.
Dr. Busch: Irwin Memorial Blood Bank, 270 Masonic Avenue, San Francisco, CA 94118-9990.
Drs. Galleshaw and Shaw: University of Alabama at Birmingham, 1900 University Boulevard, THT 513, Birmingham, AL 35294. Dr. Mosley: University of Southern California, 1840 North Soto Street (EDM 108), Los Angeles, CA 90032.
  • From the University of California, San Francisco, and Irwin Memorial Blood Center, San Francisco, California; the University of Alabama at Birmingham, Birmingham, Alabama; and the University of Southern California, Los Angeles, California.*Members of the Transfusion Safety Study Group are listed in the Acknowledgments section at the end of text.
×
FULL TEXT
The following are members of the Protocol and Data Monitoring Committee: H. J. Alter, D. J. A'Allessio, G. J. Grady, P. V. Holland, N. R. Rose, L. B. Seeff, J. Wittes.
Grant Support: By contract N01-HB-4-7002, N01-HB-4-7003, and N01-HB-9-7074 from the National Heart, Lung, and Blood Institute.
Requests for Reprints: James W. Mosley, MD, University of Southern California, 1840 North Soto Street (EDM 108), Los Angeles, CA 90032.
Current Author Addresses: Dr. Donegan: University of California, San Francisco, Department of Laboratory Medicine, P.O. Box 0100, San Francisco, CA 94143.
Dr. Busch: Irwin Memorial Blood Bank, 270 Masonic Avenue, San Francisco, CA 94118-9990.
Drs. Galleshaw and Shaw: University of Alabama at Birmingham, 1900 University Boulevard, THT 513, Birmingham, AL 35294. Dr. Mosley: University of Southern California, 1840 North Soto Street (EDM 108), Los Angeles, CA 90032.
FULL TEXT
PDF
Not Available
Citations
Citation

Donegan E, Busch MP, Galleshaw JA, et al, Transfusion Safety Study Group*. Transfusion of Blood Components from a Donor with Human T-Lymphotropic Virus Type II (HTLV-II) Infection. Ann Intern Med. 1990;113:555–556. doi: 10.7326/0003-4819-113-7-555

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1990;113(7):555-556.

DOI: 10.7326/0003-4819-113-7-555

29 Citations

Related Articles
Mother-to-Child Transmission of Human T-Lymphotropic Virus Type II (HTLV-II)
Annals of Internal Medicine; 120 (4): 300-301
Guidelines for Counseling Persons Infected with Human T-Lymphotropic Virus Type I (HTLV-I) and Type II (HTLV-II)
Annals of Internal Medicine; 118 (6): 448-454
Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion Recipients: An Analysis of the Transfusion-Transmitted Viruses Study
Annals of Internal Medicine; 101 (6): 733-738
Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody
Annals of Internal Medicine; 101 (3): 310-315
View MoreView Less

Journal Club
In critically ill adults, transfusion of fresh vs standard-issue red blood cells did not differ for 90-d mortality
Annals of Internal Medicine; 163 (2): JC5
A restrictive transfusion strategy reduced 45-day mortality in patients with acute upper GI bleeding
Annals of Internal Medicine; 158 (6): JC6
View MoreView Less

Related Topics
Infectious Disease

Infectious Disease.

PubMed Articles
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Ann Intern Med 2019.
Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.
J Pharm Biomed Anal 2019;
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×